GeneDx Holdings Corp. (WGSWW)
NASDAQ: WGSWW · Real-Time Price · USD
0.250
+0.020 (8.70%)
Feb 20, 2025, 4:00 PM EST - Market closed
GeneDx Holdings Revenue
In the year 2024, GeneDx Holdings had annual revenue of $305.45M with 50.79% growth. GeneDx Holdings had revenue of $95.64M in the quarter ending December 31, 2024, with 66.57% growth.
Revenue (ttm)
$305.45M
Revenue Growth
+50.79%
P/S Ratio
10.01
Revenue / Employee
$305,450
Employees
1,000
Market Cap
3.06B
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |